Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low on Wednesday . The stock traded as low as GBX 90 ($1.16) and last traded at GBX 92.50 ($1.20), with a volume of 18033 shares trading hands. The stock had previously closed at GBX 92.50 ($1.20).
Arecor Therapeutics Price Performance
The stock has a market capitalization of £28.33 million, a price-to-earnings ratio of -506.65 and a beta of -0.21. The company has a quick ratio of 6.24, a current ratio of 2.17 and a debt-to-equity ratio of 3.55. The firm has a 50-day moving average of GBX 128.01 and a two-hundred day moving average of GBX 140.55.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- How to Use Stock Screeners to Find Stocks
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- 3 Monster Growth Stocks to Buy Now
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- What Investors Need to Know About Upcoming IPOs
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
